Advertisement

Picture BIO Deutschland German Corona Special 2021 Digital 650x80px
Document › Details

Bayer AG. (11/9/20). "Press Release: Bayer Submits Marketing Authorization Applications for Finerenone in the U.S. and the EU for Patients with Chronic Kidney Disease and Type 2 Diabetes". Berlin.

Region Region EU (European Union)
Organisation Organisation Bayer Pharma AG
  Group Bayer (Group)
Products Product finerenone (BAY 94-8862)
  Product 2 phase 3 study
Person Person Möller, Jörg (Bayer 201403–202012 Bayer HealthCare Head of Global Development LEFT 12/20)
     


   
Record changed: 2020-12-17

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top